REGENXBIO Inc. (NASDAQ:RGNX) has 168 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | -614,082 | -9.64% | $0.00 |
| Redmile Group, LLC | 31 Dec, 2025 | 0 | -324,585 | -6.92% | $0.00 |
| Integral Health Asset Management, LLC | 31 Dec, 2025 | 0 | 100,000 | 9.09% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -177,543 | -51.92% | $0.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 0 | -4,520,994 | -55.99% | $0.00 |
| 22NW, LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 10,547 | 13.82% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 36,042 | 1.08% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | 106,363 | 19.26% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 28,667 | 107.07% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 301,858 | 15.21% | $0.00 |
| Pale Fire Capital SE | 31 Dec, 2025 | 0 | 243,925 | 95.43% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | 310,520 | 18.22% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | 157,859 | 55.42% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | -66,777 | -3.61% | $0.00 |
| Voss Capital, LP | 31 Dec, 2025 | 0 | -780,000 | -72.56% | $0.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | 72,307 | 5.61% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 84,287 | 41.03% | $0.00 |
| Assenagon Asset Management S.A. | 31 Dec, 2025 | 0 | 454,977 | 64.50% | $0.00 |
| Trexquant Investment LP | 31 Dec, 2025 | 0 | -20,841 | -7.68% | $0.00 |